Industry Spotlight

CSL awards $2.5m in grants to two Australian researchers

13 October 2016 via Biotech Dispatch: Two Australian scientists have each been awarded a $1.25 million, five-year, CSL Centenary Fellowship to further research that aims to help patients beat leukaemia and examine the origins of memory to better understand Alzheimers... | READ MORE

Award for ResApp

13 October 2016 via Biotech Dispatch: ResApp Health ;(ASX: RAP) has won the Innovation Excellence Award, one of three main awards at the Tech23 2016 Awards Ceremony held earlier this week in Sydney. Held annually for the past seven years, Tech23 is a national forum ... | READ MORE

Government considering new innovation fund

11 October 2016 via Biotech Dispatch: Innovation minister Greg Hunt is exploring the value of a broader National Innovation Fund based on matching debt or equity, rather than grants, for mid-stage commercialisation. Mr Hunt raised the idea in a CEDA State of the Na... | READ MORE

New cancer therapies grabbing headlines

11 October 2016 via Biotech Dispatch: Significant news in the development of cancer therapies during the European Society for Medical Oncology (ESMO) 2016 Congress in Copenhagen that wraps up today. Immunotherapies have led the way, headlined by MSDs KEYTRUDA (pembr... | READ MORE

Ministerial responsibilities confirmed

6 October 2016 via Biotech Dispatch: Confirmation Health Minister Sussan Ley will take personal responsibility for implementation of changes to the regulation of medicines and medical devices. The charter letters splitting responsibilities between the three health p... | READ MORE

Bill Ferris: we have to get better at collaboration

6 October 2016 via Biotech Dispatch: Bill Ferris AC, chair of Innovation and Science Australia, has called for greater collaboration between Australian businesses and publicly funded research institutions in a speech delivered at the Westmead Research Hub. Mr Ferris... | READ MORE

Funding boost for Australian healthcare startups

5 October 2016 via Biotech Dispatch: Australias innovative healthcare and biomedical research sectors are set for a boost with the launch of a new venture capital fund. “This is a breakthrough moment for many earlier stage, unlisted companies,” said BioS... | READ MORE

TGA approval for CSL Behring's long-acting haemophilia treatment

5 October 2016 via Biotech Dispatch: The TGA has approved CSL Behrings IDELVION (albutrepenonacog alfa) for use in patients with haemophilia B (congenital factor IX deficiency). The therapy is indicated in all patients with haemophilia B for: routine prophylaxis to ... | READ MORE

Review recommends reform of R and D Tax Incentive

29 September 2016 via Biotech Dispatch: The review of the R&D Tax Incentive has found the program falls short of meeting its stated objective of additionality and spillovers, recommending a series of changes including the introduction of a premium designed to address... | READ MORE

AusBiotech concern over $2M R and D tax cap

29 September 2016 via Biotech Dispatch: AusBiotech has expressed concern over some recommendations contained in the review of the R&D Tax Incentive. According to AusBiotech CEO, Mr Glenn Cross, the biotechnology sector has a mixed response to the review. “The... | READ MORE

Previous page | Next page
Jump to page